Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 52

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 52
---
of. These designations, powers, rights and preferences could include voting rights, dividend rights, dissolution rights, conversion
rights, exchange rights, redemption rights, liquidation preferences, and the number of shares constituting any series or the designation
of such series, any or all of which may be greater than the rights of common stock. The issuance of preferred stock could adversely affect
the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation.
In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing change in our control or other
corporate action.

Specific Terms of a Series of Preferred Stock

The preferred stock we may offer under this prospectus
will be issued in one or more series. A prospectus supplement will discuss the following features of the series of preferred stock to
which it relates:

| ● | the designations and stated value per share; |

| ● | the number of shares offered; |

| ● | the amount of liquidation preference per share; |

| ● | the public offering price at which the preferred stock will be issued; |

| ● | the dividend rate, the method of its calculation, the dates on which dividends would be paid and the dates, if any, from |

| ● | which dividends would cumulate; |

| ● | any redemption or sinking fund provisions; |

| ● | any conversion or exchange rights; and |

| ● | any additional voting, dividend, liquidation, redemption, sinking fund and other rights, preferences, privileges, limitations and 
 restrictions.                                                                                                                     |

<div align='center'>10

DESCRIPTION OF
DEBT SECURITIES WE MAY OFFER</div>

General

The debt securities that we may issue will constitute
debentures, notes, bonds or other evidences of indebtedness of ENDRA, to be issued in one or more series, which may include senior debt
securities, subordinated debt securities and senior subordinated debt securities. The particular terms of any series of debt securities
we offer, including the extent to which the general terms set forth below may be applicable to a particular series, will be described
in a prospectus supplement relating to such series.

Debt securities that we may issue will be issued
under an indenture between us and a trustee qualified to act as such under the Trust Indenture Act of 1939. We have filed the form of
the indenture as an exhibit to the registration statement of which this